Table 3.
Metastasis Relationship to Histopathologic Markers in Patients with Breast Cancer (BCa) Younger Than 40 Years of Age
| Metastasis | ||||
|---|---|---|---|---|
| Yes | No | p | OR (95% CI) | |
| (n = 4) | (n = 12) | |||
| PR Negative | 100.0% (4) | 25.0% (3) | 0.01* | - |
| ER Negative | 75.0% (3) | 25.0% (3) | 0.03* | 12 (0.006-1.09) |
| Her2+ | 0.0 | 25.0% (3) | 0.33 | - |
| Ki67+ | 100.0% (4) | 50.0% (6) | 0.42 | - |
| (ER-/PR-/Her2-) | 75%(3) | 16.6% (2) | 0.05* | 12 (0.77-86.36) |
| (ER+/PR+/Her2+) | 0.0 | 8.3% (1) | 0.46 | - |
| (ER-/PR-) | 75.0% (3) | 16.6% (2) | 0.12 | 6 (0.56-63.98) |
| (ER+/PR+) | 25.0% (1) | 66.6% (8) | 0.05* | PF 9.33 (0.008-1.40) |
| (ER+/PR+/Her2-) | 25.0% (1) | 50.0% (6) | 0.42 | PF 2.25 (0.05-3.97) |
*
Statistical significance; PF, Protection Factor; +, Positive marker; -, Negative marker; PR, Progesterone Receptor; ER, Estrogen Receptor